MarketFriction

Apollo Hospitals Enterprise Ltd

NSE APOLLOHOSP · BSE 508869 · Hospital
₹8,133.50 -0.39%
NSE close2026-10-01
52 week range6,696.50 - 9,070.50
Market cap₹1,24,503 Cr.
P/E59.2
Nifty 50Nifty 100Nifty 200Nifty 500Nifty Healthcare IndexNifty InfrastructureNifty India Consumption No price band Delivery 55.5%

Price

Drag to pan, scroll or pinch to zoom. Ruler (or Shift + drag) measures a move.Dashed lines: 52 week high and low. Prices adjusted for splits and bonuses.

Financials

Consolidated, Rs crore
Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales4,8474,8514,9445,0865,5895,5275,5925,8426,3046,4776,6067,044
Expenses4,2194,2374,3034,4104,7744,7654,8224,9905,3625,5125,5945,951
Operating Profit6286146406758167627708529419651,0111,092
OPM %13%13%13%13%15%14%14%15%15%15%15%16%
Other Income262937494469725461485462
Interest111113119116118110115108110113119120
Depreciation163167190177184185211215218219224235
Profit before tax379363368430557536516583675682722799
Tax %34%30%30%27%29%29%20%24%27%24%24%24%
Net Profit249254258316396379414441494516551610
EPS in Rs16.2017.0617.6521.2326.3425.8927.1030.1033.1934.9336.8140.39
Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales6,1507,2568,2439,61711,24710,56014,66316,61219,05921,79425,22826,430
Expenses5,4656,5227,4428,5489,6569,42012,47414,54816,66518,76121,44922,420
Operating Profit6847348011,0701,5911,1402,1892,0652,3943,0333,7794,010
OPM %11%10%10%11%14%11%15%12%13%14%15%15%
Other Income9260242622210336875123222207226
Interest180257295327533449379381449458450462
Depreciation264314359396620573601615687758876896
Profit before tax3322221713736602211,5781,1441,3802,0392,6612,877
Tax %29%41%65%47%34%38%30%22%32%26%25%
Net Profit235131602004321371,1088449351,5052,0032,172
EPS in Rs16.9915.888.4416.9632.7010.4673.4256.9762.50100.56135.04145.32
Dividend Payout %35%38%59%35%18%29%16%26%26%13%15%
10 Years5 Years3 YearsTTM1 YearLast Year
Compounded Sales Growth15%19%15%17%
Compounded Profit Growth23%76%32%34%
Stock Price CAGR21%14%19%17%
Return on Equity13%17%18%21%
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital707070707070727272727272
Reserves3,1023,2623,2443,1823,2643,2704,5315,5516,1266,8648,1409,408
Borrowings1,9922,8343,1253,4273,6733,5964,1604,0684,3325,3337,8648,493
Other Liabilities1,2961,1951,6651,9172,1594,3542,6293,5703,8864,4744,5684,210
Total Liabilities6,4597,3608,1038,5969,16611,28911,39213,26114,41616,74220,64422,183
Fixed Assets3,2443,9974,5914,7734,9827,4326,7788,2968,5209,66410,98812,272
CWIP533562347712822236234466108739211,032
Investments3113524063524624341,3438165749862,4872,179
Other Assets2,3722,4482,7592,7592,9013,1873,0374,1044,7125,2196,2486,700
Total Assets6,4597,3608,1038,5969,16611,28911,39213,26114,41616,74220,64422,183
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity4705976235379051,2931,2651,6961,3771,9202,1362,856
Cash from Investing Activity-759-888-1,152-405-711-289-880-747-857-1,537-3,383-2,145
Cash from Financing Activity392330477-108-215-910-340-792-633-3111,319-478
Net Cash Flow10339-5224-209444158-1137273233
Free Cash Flow-396-393-46-842337829841,044252785439925
CFO/OP77%108%103%83%103%100%108%87%85%100%86%92%
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days433638373933464449485150
Inventory Days504947514649162117171615
Days Payable596651555660747982887263
Cash Conversion Cycle341934332922-12-14-16-23-63
Working Capital Days2416278-3-8-45-1-19-6-25
ROCE %12%9%8%7%10%14%8%17%14%15%17%17%
Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters29.33%29.33%29.33%29.33%29.33%29.33%29.34%29.34%28.02%28.02%28.02%28.02%
FIIs46.15%46.25%45.63%43.92%45.37%45.27%42.74%43.49%44.20%43.54%42.62%41.49%
DIIs18.59%18.87%19.55%21.13%19.94%19.97%22.29%21.34%21.12%21.50%22.76%23.72%
Government0.23%0.23%0.23%0.23%0.23%0.23%0.23%0.23%0.23%0.23%0.23%0.23%
Public5.68%5.32%5.26%5.38%5.12%5.21%5.41%5.61%6.43%6.71%6.39%6.53%
No. of Shareholders1,31,5651,19,5781,30,6641,27,7541,19,2451,27,8021,34,0581,41,0071,60,5561,78,6481,74,6101,74,281

Fundamentals

Market Cap₹ 1,24,503 Cr.
Current Price₹ 8,659
Stock P/E59.2
Book Value₹ 659
ROCE17.4 %
ROE21.2 %
Dividend Yield0.23 %
Face Value₹ 5.00
Compounded Sales Growth (TTM)17%
Compounded Profit Growth (TTM)34%
Consolidated figures.
Valuation
Market capRs 116,947 Cr
Enterprise valueRs 124,323 Cr
P/E (TTM)55.97x
Price to book12.34x
Price to sales4.42x
EV / EBITDA29.35x
EV / EBIT37.24x
EV / sales4.70x
Price to cash flow40.95x
Earnings yield1.79%
Dividend yield0.25%
P/E, 3-year average74.15x
P/B, 3-year average12.01x
P/E, 5-year average71.93x
P/B, 5-year average11.51x
Profitability
Operating margin (excl. other income)14.98%
Operating margin (incl. other income)15.80%
EBITDA margin16.02%
Pre-tax margin10.89%
Net profit margin7.91%
Net margin, latest quarter8.24%
ROE21.95%
ROCE18.27%
ROA9.07%
ROE, 3-year average18.24%
ROCE, 3-year average17.32%
ROA, 3-year average7.52%
ROE, 5-year average17.85%
ROCE, 5-year average17.65%
ROA, 5-year average7.41%
ROIC (approx.)14.91%
Tax rate24.74%
Other income / net worth2.19%
Growth
Sales growth (latest year)15.76%
Profit growth (latest year)34.29%
Sales CAGR, 3 years14.94%
Sales CAGR, 5 years19.03%
Profit CAGR, 3 years33.34%
Profit CAGR, 5 years66.80%
Sales growth QoQ6.63%
Profit growth QoQ9.71%
Sales growth YoY (latest quarter)20.56%
Profit growth YoY (latest quarter)34.17%
Per share
EPS (TTM)Rs 145.32
EPS (latest year)Rs 135.04
EPS (latest quarter)Rs 40.39
EPS, 3-year averageRs 99.37
EPS, 5-year averageRs 85.70
Book value per shareRs 659.33
Sales per shareRs 1,838.16
Cash flow per shareRs 198.61
Free cash flow per shareRs 64.33
Dividend per share (latest year)Rs 20.00
Dividend per share, 3-year averageRs 16.22
Dividend per share, 5-year averageRs 15.08
Dividends
Dividend payout14.81%
Dividend payout, 3-year average17.67%
Dividend payout, 5-year average19.07%
Efficiency
Asset turnover1.14x
Fixed asset turnover2.06x
Inventory turnover30.84x
Inventory days12 days
Debtor days50 days
Debtors turnover7.24x
Creditor days63 days
Cash conversion cycle3 days
Working capital days-25 days
Leverage
Total debtRs 8,493 Cr
Cash and bankRs 1,117 Cr
Net debtRs 7,376 Cr
Debt to equity0.90x
Net debt / EBITDA1.74x
Interest coverage7.23x
Current ratio (filing 2026-03-31)1.06x
Quick ratio (filing 2026-03-31)0.98x
Trade payables (filing 2026-03-31)Rs 2,252 Cr
Owners' fund to total sources42.74%
Debt to assets38.29%
Cash flow
Cash from Operating Activity (latest year)Rs 2,856 Cr
Cash from Investing Activity (latest year)Rs -2,145 Cr
Cash from Financing Activity (latest year)Rs -478 Cr
Net Cash Flow (latest year)Rs 233 Cr
Free cash flow (latest year)Rs 925 Cr
FCFE (approx.: FCF + change in debt)Rs 1,554 Cr
Cash from ops / profit, 5 years1.56x
Sales to cash flow8.83x
Statement figures
Net sales (TTM)Rs 26,430 Cr
Net sales (latest year)Rs 25,228 Cr
Sales (latest quarter)Rs 7,044 Cr
Operating profit excl. other income (latest year)Rs 3,779 Cr
Operating profit (latest quarter)Rs 1,092 Cr
Other income (TTM)Rs 226 Cr
EBITDA (TTM)Rs 4,235 Cr
PBDT (TTM)Rs 3,774 Cr
Profit before tax (TTM)Rs 2,877 Cr
Tax (latest year)Rs 658 Cr
Net profit (TTM)Rs 2,090 Cr
Net profit (latest year)Rs 1,942 Cr
Net profit (latest quarter)Rs 581 Cr
Depreciation (TTM)Rs 896 Cr
Depreciation (latest quarter)Rs 235 Cr
Interest (TTM)Rs 462 Cr
Cost of goods sold (latest year)Rs 16,727 Cr
Total expenditure (latest year)Rs 21,449 Cr
Total income (latest year)Rs 25,436 Cr
Share capitalRs 72 Cr
ReservesRs 9,408 Cr
Shareholders' fundsRs 9,480 Cr
Total assetsRs 22,183 Cr
Net blockRs 12,272 Cr
Capital work in progressRs 1,032 Cr
InvestmentsRs 2,179 Cr
ReceivablesRs 3,485 Cr
InventoryRs 542 Cr
Other liabilitiesRs 4,210 Cr
Shares outstanding (crore)14.38
Ownership
Promoter holding28.02% (-1.32 in a year)
Computed by MarketFriction from the consolidated statements. Returns use average balances.
P/E 56.0 is at the 4th percentile of its own 8.7-year range (median 81.0, low 42.7, high 385.8).
P/B 12.34 is at the 57th percentile (median 11.55).
Monthly. Market cap from split-adjusted price; profit and book value as reported by that month. A low percentile means cheap versus its own history, not cheap versus peers.
PeriodAPOLLOHOSPNifty 50Difference
1 week-8.5%-2.8% -5.7 pts
1 month-7.1%-6.8% -0.3 pts
3 months-8.5%-7.6% -0.9 pts
6 months+9.6%+0.4% +9.2 pts
1 year+6.7%-9.9% +16.6 pts
2 years+13.7%-13.6% +27.3 pts
3 years+58.3%+14.2% +44.1 pts
5 years+82.4%+27.9% +54.5 pts
351 mutual fund schemes hold about ₹19,154 Cr. Over three months 246 bought more and 53 sold (share counts, price move removed).
FundWeightEst. Cr3m shares
Axis Large Cap Fund2.95%926 +10%
HDFC Flexi Cap Fund0.68%768 +25%
Kotak Arbitrage Fund(M1.01%762 +128%
Axis Focused Fund5.20%595 +9%
ICICI Pru Balanced Advantage Fund(M0.73%549 +16%
SBI Flexicap Fund2.17%503 +9%
Franklin India Flexi Cap Fund2.58%500 +11%
Mirae Asset Large Cap Fund1.28%494 -2%
Nippon India Pharma Fund5.15%488 +7%
Invesco India Contra Fund2.09%431 +2%
Motilal Oswal Large & Midcap Fund2.10%423 -23%
Kotak Mid Cap Fund0.56%400 +6%
Motilal Oswal Large & Midcap Fund2.10%387 -23%
Mirae Asset ELSS Tax Saver Fund1.18%310 +12%
Aditya Birla SL Flexi Cap Fund1.01%293 -20%
Aditya Birla SL Large Cap Fund0.99%293 -10%
SBI Healthcare Opp Fund4.91%285 +3%
DSP India T.I.G.E.R Fund4.15%268 +9%
Mirae Asset Large & Midcap Fund0.56%254 -30%
DSP Healthcare Fund6.47%248 +47%
Motilal Oswal Flexi Cap Fund1.75%248 -42%
UTI Nifty 50 Index Fund0.83%245 +11%
HDFC ELSS-Tax Saver Fund1.53%245 +10%
Franklin India Large Cap Fund3.08%230 +163%
Mirae Asset Healthcare Fund5.91%210 +6%

Red flags

F-score 7 of 8
No red flags in the latest statements and filings.
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.

Insider trades

NSE insider and takeover-code disclosures
DateWhoRoleSideSharesValueHow
2025-12-29HARSHAD REDDYPromotersother110,000Inter-se-Transfer
2025-12-29p vijayakumar reddyPromotersother220,000Inter-se-Transfer
2025-12-29KARTHIK ANANDPromotersother110,000Inter-se-Transfer
2025-11-17SUNEETA REDDYPromotersother150,000Rs 112.31 CrRevokation of Pledge
2025-10-16PCR INVESTMENTS LIMITEDPromotersother2,300,000Rs 180.71 CrRevokation of Pledge
2025-09-29K VISHWESHWAR REDDYPromotersother70,000Rs 52.11 CrPledge Creation
2025-09-11SUNEETA REDDYPromotersother175,000Rs 137.89 CrRevokation of Pledge
2025-09-10K VISHWESHWAR REDDYPromotersother277,946Rs 219.62 CrRevokation of Pledge
2025-09-03SUNEETA REDDYPromotersother575,000Rs 444.82 CrRevokation of Pledge
2025-08-29K VISHWESHWAR REDDYPromotersother110,000Rs 83.71 CrPledge Creation
2025-08-28PCR INVESTMENTS LIMITEDPromotersother1,225,000Rs 946.68 CrRevokation of Pledge
2025-08-22SUNEETA REDDYPromoterssell1,897,239Rs 1483.42 CrMarket Sale
Latest disclosed trades by insiders, promoters and large holders. Grants, option exercises and pledges show as "other". A filing is a fact, not a signal on its own.

Latest quarter

Jun 2026
Sales ₹7,044 Cr +20.6% vs Jun 2025. Net profit ₹610 Cr +38.3%.

Activity

Compare
CompanyMcap (Cr)P/EROCE
Manipal Health Enterprises Ltd98,35711112.1 %
Max Healthcare Institute Ltd95,58963.814.7 %
Aster DM Quality Care Ltd63,97617711.6 %
Fortis Healthcare Ltd62,05858.213.4 %
Global Health Ltd38,04866.417.4 %
Narayana Hrudayalaya Ltd36,57942.415.5 %
Krishna Institute of Medical Sciences Ltd32,3361559.50 %
Dr Agarwals Health Care Ltd15,70110610.9 %
Rainbow Childrens Medicare Ltd13,89248.517.4 %
Park Medi World Ltd11,89842.819.5 %
Yatharth Hospital & Trauma Care Services Ltd10,67658.912.9 %
Healthcare Global Enterprises Ltd10,5052188.30 %
Jupiter Life Line Hospitals Ltd8,59144.914.8 %
Kovai Medical Center & Hospital Ltd6,57925.722.6 %
Artemis Medicare Services Ltd5,81850.414.5 %
No bulk or block deals on record.
Ex-dateActionFactor
2026-08-14Dividend - Rs 10 Per Sh
2026-02-16Interim Dividend - Rs 10 Per Sh
2025-08-19Dividend - Rs 10 Per Share
2025-02-14Interim Dividend - Rs 9 Per Share
2024-08-16Annual General Meeting/Dividend - Rs 10 Per Share
2024-02-20Interim Dividend - Rs 6 Per Share
2023-08-18Annual General Meeting/Dividend - Rs 9 Per Share
2023-02-24Interim Dividend - Rs 6 Per Share
2022-08-18Annual General Meeting/Dividend - Rs 11.75 Per Share
2021-08-18 Annual General Meeting/Dividend - Rs 3 Per Share
2020-09-17 Annual General Meeting/Dividend - Rs 2.75 Per Share
2020-02-25 Interim Dividend - Rs 3.25 Per Share
2019-09-12 Annual General Meeting/Dividend - Rs 6 Per Share
2018-09-12 Annual General Meeting/Dividend- Rs 5 Per Share
2017-09-07 Annual General Meeting/Dividend - Rs 6/- Per Share
2016-03-22 Interim Dividend - Rs 6/- Per Share (Purpose Revised)
2015-07-30Annual General Meeting/Dividend Rs 5.75 Per Share
2014-08-13Annual General Meeting And Dividend Rs.5.75 Per Share
2013-07-25Annual General Meeting And Dividend Rs.5.50 Per Share
2012-07-26Annual General Meeting/Dividend Rs 4 Per Share
2011-07-07Annual General Meeting And Dividend Rs.3.75 Per Share
2010-09-02Face Value Split From Rs.10/- To Rs.5/-0.5000
2010-07-15Annual General Meeting And Dividend Rs.7/- Per Share
2009-08-20Agm/Div-Rs.6.50 Per Share
2008-08-11Agm/Dividend - 60%
2007-08-09Agm/Fin Div-Rs.2/- Per Sh
2007-03-22Interim Dividend-30% Purpose Revised
2006-07-27Agm/Dividend-45%
DateTypeWhat it says
2026-09-03General UpdatesGeneral Updates
2026-08-25General UpdatesGeneral Updates
2026-08-25Shareholder meetingProceedings of Annual General Meeting held on August 25, 2026. Further, the company has informed the Exchange regarding voting results along with copy...
2026-08-19Concall / analyst meetTranscript
2026-08-13Concall / analyst meetLink of Recording
2026-08-12Investor PresentationInvestor Presentation
2026-08-12Concall / analyst meetPresentation
2026-08-12General UpdatesGeneral Updates
2026-08-12Press ReleaseA press release dated August 12, 2026, titled "Apollo Hospitals Q1FY27 Results".
2026-08-12Board meeting outcomeApollo Hospitals Enterprise Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.
2026-08-04General UpdatesGeneral Updates
2026-08-01General UpdatesGeneral Updates
2026-08-01Shareholder meetingNotice of Annual General Meeting to be held on August 25, 2026
2026-07-18Concall / analyst meetSchedule of meet
2026-07-03UpdatesCertificate under Regulation 74(5) for the period ended 30th June 2026.
2026-06-26Scheme of ArrangementScheme of Arrangement
2026-06-26Shareholder meetingVoting results.
2026-06-24Scheme of ArrangementScheme of Arrangement
2026-06-24Shareholder meetingProceedings of Court Convened General Meeting held on Jun 24, 2026 along with a copy of minutes.
2026-06-19Scheme of ArrangementScheme of Arrangement
2026-06-16Disclosure under SEBI TakeovPreetha Reddy has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acq...
2026-06-15Scheme of ArrangementScheme of Arrangement - Additional information in relation to the scheme
2026-05-30ResignationResignation of Mr DINESH MADHAVAN as Other of the company w.e.f. May 30, 2026.
2026-05-27General UpdatesGeneral Updates
2026-05-25General UpdatesGeneral Updates
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
Put / call open interest0.60
Max pain (expiry 2026-10-27)8,300
Largest call open interest at9,000
Largest put open interest at8,000
Implied volatility, at the money22.4%
Underlying at snapshot8,133.50
Open interest by strike around the price, nearest expiry. End-of-day NSE snapshot, 01-Oct-2026 15:40:00. Max pain is the strike where option buyers together would lose the most at expiry.
Trade dateShares sold short
2026-09-3025
2026-09-295,514
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Order dateForumCase
2020-06-24NCLTApollo Hospitals Enterprises Ltd. Vs Apollo Pharmacies Ltd.
2019-02-05CESTATAPOLLO HOSPITALS ---VS.--- RAIPUR
2018-05-31CESTATAPOLLO HOSPITALS ---VS.--- RAIPUR
Orders from NCLT, NCLAT and CESTAT naming the company. Click a row for the order.
Scrip PE is greater than 50 (4 trailing quarters)

Quick answers

What is the market cap of Apollo Hospitals Enterprise Ltd?

Apollo Hospitals Enterprise Ltd (APOLLOHOSP) has a market capitalisation of Rs 1,24,503 Cr. at the 2026-10-01 close.

What is the P/E ratio of Apollo Hospitals Enterprise Ltd?

Apollo Hospitals Enterprise Ltd trades at a P/E of 59.2 on trailing twelve-month profit, at the 2026-10-01 close.

What were Apollo Hospitals Enterprise Ltd's latest quarterly results?

In the Jun 2026 quarter, Apollo Hospitals Enterprise Ltd sales was Rs 7,044 Cr (+20.6% vs Jun 2025) and net profit was Rs 610 Cr.

What is the 52-week high and low of Apollo Hospitals Enterprise Ltd?

The 52-week high is Rs 9,070.50 and the 52-week low is Rs 6,696.50.

Data: NSE and BSE daily reports, company filings. Numbers only, not investment advice, not a SEBI-registered research service.AboutMethodologyFAQResearchContactTermsPrivacyDisclaimerUpdated 2026-10-03